142 related articles for article (PubMed ID: 34739174)
1. Usefulness of brain natriuretic peptide to distinguish Kawasaki disease from cervical lymphadenitis.
Muto T; Masuda Y; Nakamura N; Numoto S; Kodama S; Miyamoto R; Miyata K; Hayakawa T; Mori H; Kuroyanagi Y; Akaihata M; Iwayama H; Kurahashi H; Shimomura Y; Nagai T; Hori T; Agata H; Okumura A
Pediatr Int; 2022 Jan; 64(1):e15050. PubMed ID: 34739174
[TBL] [Abstract][Full Text] [Related]
2. Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease.
Kanegaye JT; Van Cott E; Tremoulet AH; Salgado A; Shimizu C; Kruk P; Hauschildt J; Sun X; Jain S; Burns JC
J Pediatr; 2013 Jun; 162(6):1259-63, 1263.e1-2. PubMed ID: 23305955
[TBL] [Abstract][Full Text] [Related]
3. Brain natriuretic peptide as a clinical screening tool for the diagnosis of Kawasaki disease.
Jung JH; Hwang S; Jung JY; Park JW; Lee EJ; Lee HN; Kim JH; Kim DK; Kwak YH
Medicine (Baltimore); 2023 Jul; 102(29):e34319. PubMed ID: 37478221
[
